In the wake of recent global health challenges, the demand for high-quality Antiviral Drugs has surged unprecedentedly. As a leading Antiviral Drugs Factory & Exporter, Hangzhou Jeci Biochem Technology Co., Ltd. stands at the intersection of innovation and accessibility. The global pharmaceutical market is currently witnessing a paradigm shift towards more robust, bio-available, and cost-effective antiviral treatments, not only for human healthcare but also within the massive livestock and poultry sectors.
The industrial status of these drugs is defined by rigorous GMP (Good Manufacturing Practice) standards and the integration of advanced chemical synthesis. For procurement officers, the focus has shifted from mere pricing to supply chain stability and the purity of Active Pharmaceutical Ingredients (APIs).
The convergence of artificial intelligence and medicinal chemistry is accelerating the discovery of new antiviral molecules. As a forward-thinking Chinese factory, we utilize AI-driven data analysis to optimize the synthesis of intermediates, ensuring a higher yield and lower environmental impact.
Purchasing departments worldwide—from India to Southeast Asia and Europe—are seeking partners who can provide more than just a product. They require documentation support, including DMF (Drug Master Files) and COA (Certificate of Analysis) that meet stringent local health authority standards.
Our role as an exporter is to bridge the gap between high-volume manufacturing and localized application. Whether it is Poultry Antiviral Powder for large-scale farms in Brazil or Isoprinosine Powder for clinical intermediates in South Korea, we ensure that every batch is traceable and consistent.
Antiviral drugs are no longer confined to hospitals; their application in the agricultural sector is vital for global food security. In the poultry industry, viral outbreaks such as Newcastle disease or avian influenza can devastate livelihoods. Our Chinese herbal viral respiratory specific drugs represent a blend of traditional wisdom and modern science, providing effective solutions that minimize antibiotic resistance.
Why choose a China-based partner like Hangzhou Jeci Biochem Technology Co., Ltd.? The answer lies in the unique combination of industrial scale, specialized talent, and logistical efficiency. China remains the world's largest producer of pharmaceutical raw materials, offering a cost-to-quality ratio that is unmatched globally.
Collaborating with top-tier research institutes to develop next-generation antiviral molecules.
Strict adherence to GMP systems and internal quality audits for every export batch.
Located in Hangzhou, Zhejiang, we leverage world-class logistics for rapid sea and air freight.
Assisting overseas companies with registration and sales channel expansion in the Chinese market.
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Drugs and intermediates are widely used in the following aspects (partial):
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
SJ medical
